Skip to content
Home/Companies/Healthcare/Ermium Therapeutics

Ermium Therapeutics

Healthcare·France·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Ermium Therapeutics?

Ermium Therapeutics is currently owned by Erganeo through Erganeo (2012 vintage), since 2019.

Hand-verified · updated 2026-04-21

Erganeo
Investor
Erganeo
Erganeo · 2012 · VC

Key facts

HQFrance
SectorHealthcare

More from Erganeo

Other portfolio companies in the same fund.

PegmaTiss BioTech
Active
HealthcareFrance· 2023
Izonics
Active
IndustrialsFrance· 2022
Persea
Active
HealthcareFrance· 2022
AbilyCare
Active
HealthcareFrance· 2021
Auressens
Auressens
Active
HealthcareFrance· 2021
Cobot One
Cobot One
Active
IndustrialsFrance· 2021

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Ermium Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Ermium Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Ermium Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue